Conference Summaries: Day Four<BR> Thursday, February 8, 2001

The Body Covers: The 8th Conference on Retroviruses and Opportunistic Infections

Conference Summaries: Day Four
Thursday, February 8, 2001

Hear the Lectures from The 8th Conference on Retroviruses and Opportunistic Infections
Hear the Symposia from The 8th Conference on Retroviruses and Opportunistic Infections
Search through the conference's original abstracts

Advances in Antiretroviral Chemotherapeutics (Session 95)
Coverage by Paul E. Sax, M.D.
- Optimizing Available Antiretroviral Therapies (Symposium 24)
- New Antiretroviral Drugs (Symposium 25)
Late Breakers (Session 96)
Coverage by Pablo Tebas, M.D.
- A Controlled Phase II Trial Assessing Three Doses of T-20 in Combination with Abacavir, Amprenavir, Low-Dose Ritonavir and Efavirenz in Non-Nucleoside-Naive Protease-Inhibitor-Experienced HIV-1 Infected Adults (Late Breaker 5)
- HAART-Associated Bone Mineral Loss Through Increased Rate of Bone Turnover in Vertically HIV-Infected Children (Late Breaker 9)

Previous Day's Sessions

Return to The Body's coverage of
The 8th Conference on Retroviruses and Opportunistic Infections.

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.